Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The serotonin 5-HT1B receptor (also known as 5-hydroxytryptamine receptor 1B) is a subtype of serotonin receptors encoded by the HTR1B gene. It belongs to the G protein-coupled receptor (GPCR) superfamily, specifically coupling to Gi/o proteins, and features seven transmembrane domains. The receptor primarily functions as an inhibitory receptor, modulating neurotransmitter release and playing critical roles across neurological functions such as mood, aggression, stress, anxiety, and memory. Its pharmacological targeting underpins several therapies for migraines and potentially psychiatric or neurodegenerative disorders.
Vasoconstriction via cerebral arteries; inhibition of neurotransmitter exocytosis via Gi/o protein activation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Serotonin 5-HT1B Receptor (5-HT1B).